ENXTPA:TNGBiotechs
Transgene (ENXTPA:TNG) TTM Loss Of €37.5m Reinforces Bearish Earnings Narrative
Transgene (ENXTPA:TNG) has opened FY 2025 with first half revenue of €4.6 million and a basic EPS loss of €0.15, alongside a net income loss of €19.3 million. Over the past three reported half year periods, revenue has moved from €3.4 million in H1 2024 to €3.0 million in H2 2024 and now €4.6 million in H1 2025. Basic EPS losses over those same halves were €0.16, €0.13 and €0.15 respectively, against trailing twelve month revenue of €7.2 million and a net income loss of €37.5 million. With...